␤-Catenin and plakoglobin (or ␥-catenin) are closely related proteins with similar, but not identical, functions. Both catenins are cytoplasmic components of cadherin-containing cell-cell adherens junctions. Plakoglobin is also an essential constituent of the desmosomal cytoplasmic plaque (reviewed in reference 5).
␤-Catenin plays a key role in the Wnt/Tcf signal transduction pathway. In epithelial cells, ␤-catenin is mainly engaged in the formation of cell-cell junctions, and nonjunctional ␤-catenin is rapidly degraded by the ubiquitin-proteasome system (1, 20, 36) . The activation of Wnt signaling results in the stabilization of nonjunctional ␤-catenin, its translocation to the nucleus, binding to Lef/Tcf transcription factors, and transactivation of Lef/Tcf target genes. In mammals, these genes include those encoding such important regulators of cellular functions as cyclin D1, c-Myc, c-jun, CD44, and Nr-CAM (http://www.stanford .edu/ϳrnusse/pathways/targets.html). Wnt/␤-catenin signaling is involved in the regulation of cell fate during development (8) , and its aberrant activation due to ␤-catenin stabilization contributes to tumor progression (reviewed in reference 39). The involvement of plakoglobin in Wnt signaling is still uncertain, although in some cell types Wnt can induce the accumulation of plakoglobin (7, 22, 38) . The functional consequences of elevated cellular plakoglobin levels are, however, unclear. Plakoglobin overexpression can induce cell transformation (27) , but the restoration of plakoglobin expression in highly tumorigenic cells abolishes tumorigenicity (44) . Overexpression of plakoglobin in the epidermis has been reported to decrease proliferation in the interfollicular regions and to shorten the hair follicle cycle, resulting in shorter hairs (9) . In Xenopus embryos, ectopic expression of plakoglobin leads to its nuclear accumulation and axis duplication (24) , mimicking ␤-catenin signaling.
The ␤-catenin and plakoglobin central domains, consisting of armadillo repeats, are structurally similar and bind to numerous protein partners including Tcf factors, cadherins, adenomatous polyposis coli (APC), and axin (51) . The N-and C-terminal domains of ␤-catenin and plakoglobin display less sequence similarity (reviewed in reference 13). However, both catenins can be phosphorylated by glycogen synthase kinase 3␤ (GSK-3␤) on N-terminal serine residues (1, 26) , and GSK-3␤-mediated phosphorylation leads to proteasomal degradation of ␤-catenin and plakoglobin (1, 20, 36, 42) . Point mutations or deletion of the N-terminal phosphorylation sites result in the stabilization of ␤-catenin but have no effect on the half-life of plakoglobin (49) . Since plakoglobin is localized almost entirely to desmosomes and adherens junctions, with a very limited soluble pool, it is inaccessible to the degradation machinery (42) . Nevertheless, the N-terminal GSK-3␤ phosphorylation sites are important for plakoglobin stability, since overexpression of axin, which promotes its GSK-3␤-dependent phosphorylation, leads to plakoglobin degradation (26) .
␤-Catenin and plakoglobin have transactivation domains at their C termini (21, 45) , and ␤-catenin was suggested to activate target gene transcription by recruiting components of the basal transcription machinery to the corresponding promoter regions (21) . Despite the high homology in the armadillo domain, ␤-catenin has a higher affinity for Tcf transcription factors than plakoglobin (49, 52) , and a recent study showed that Tcf-4 has distinct binding sites for the two catenins (34) .
Current knowledge concerning the ability of plakoglobin to activate transcription is incomplete. Plakoglobin may stimulate ␤-catenin signaling by sequestering components of the GSK-3␤-APC-axin degradation system, which results in the stabilization of ␤-catenin (25, 26, 32, 45) . Moreover, a recent study demonstrated that plakoglobin transactivates the Lef/Tcf-reporter TOPFLASH and the Nr-CAM and cyclin D1 promoters in ␤-catenin-null embryonic stem cells (12) . Thus, at least in vitro, plakoglobin, like ␤-catenin, can participate in the regulation of transcription.
The activation of ␤-catenin signaling is a critical step in hair follicle induction in the embryo, in recruitment of stem cells to the lower, cycling part of hair follicles in anagen, and in lower hair follicle cell differentiation (14, 18, 28, 30, 47) . The inhibition of Tcf/␤-catenin signaling blocks hair follicle induction and leads to epidermal differentiation and the formation of epidermoid cysts from hair follicle rudiments (23, 35, 46) . In contrast, the depletion of plakoglobin does not affect hair follicle outgrowth but severely disturbs epidermal architecture and adhesion due to impaired desmosome assembly (6) .
To analyze the functions of plakoglobin in the epidermis, we generated transgenic mice expressing N-terminally truncated plakoglobin (⌬N122-PG, lacking amino acids 1 to 122) and fulllength plakoglobin under control of the keratin 5 (K5) promoter which targets transgene expression to the basal layer of the epidermis and the outer root sheath of hair follicles (transgenic lines K5-⌬N122-PG and K5-PG, respectively). ⌬N122-PG lacks the GSK-3␤ phosphorylation sites and is, therefore, protected against degradation. Due to its intact C-terminal and central segments ⌬N122-PG retains the transactivation domain, together with binding sites for numerous plakoglobin protein partners, including Lef/Tcf, APC, axin, and classical and desmosomal cadherins.
We found that while K5-PG mice display no visible change in their epidermis, the expression of ⌬N122-PG resulted in hyperplasia of the interfollicular epidermis and the formation of additional hair germs, aberrant hyperplastic hair follicles, and noninvasive hair follicle tumors. To determine whether this phenotype required ␤-catenin-mediated events or was induced by the transgene product per se, we studied the effects of ⌬N122-PG expression in ␤-catenin-null epidermis.
MATERIALS AND METHODS
Generation of transgenic mice. N-terminally deleted human plakoglobin cDNA (⌬N122-PG) and the full-length human plakoglobin cDNA were hemagglutinin (HA)-tagged at the N terminus and inserted into the blunt-ended BamHI site of the K5 expression cassette (kindly provided by J. L. Jorcano [41] ). The resulting constructs were designated K5-⌬N122-PG and K5-PG, respectively (Fig. 1A) .
FIG. 1.
Transactivation by plakoglobin and ␤-catenin ectopically expressed in keratinocytes and transgene expression in the skin. (A) The plakoglobin constructs used for expression under control of the K5 promoter in the epidermis of transgenic mice. (B) Activation (left) of the TOPFLASH luciferase reporter by ⌬N122-PG, plakoglobin, and ⌬N57-␤-catenin. Pam212 mouse keratinocytes were transiently cotransfected with TOPFLASH or FOPFLASH and, where indicated, with LEF-1 (62.5 ng), ⌬N122-PG, full-length plakoglobin, or ⌬N57-␤-catenin (each, 125 ng) plasmids. Coactivation (right) of TOPFLASH by ⌬N57-␤-catenin and ⌬N122-PG or plakoglobin. To study the effects of plakoglobin on TOPFLASH transactivation by ⌬N57-␤-catenin, various amounts (62.5, 125, and 250 ng) of ⌬N122-PG or full-length plakoglobin plasmids were cotransfected with ⌬N57-␤-catenin plasmid (125 ng). Numbers (0.5, 1.0, or 2.0) indicated the ratio of plakoglobin to ⌬N57-␤-catenin plasmid DNA. The values (bars) were corrected for transfection efficiency and represent the activation levels with respect to those obtained with TOPFLASH or FOPFLASH only. The data from a representative experiment performed in triplicate are shown with error bars. (C to E) Expression of ⌬N122-PG and plakoglobin in the skin of transgenic mice analyzed by Western blotting. Panel C shows Western blots obtained with skin protein extracts from 3-month-old male K5-⌬N122-PG and K5-PG mice (lines 44 and 1, displaying high levels of transgene expression) probed with anti-HA-tag and anti-␤-catenin antibodies. Note similar transgene expression levels in K5-PG and K5-⌬N122-PG skin.
Panel D shows protein extracts from 3-month-old male K5-⌬N122-PG mouse skin (lines 44 and 51, displaying high levels of transgene expression). Anti-HA-tag antibody detects transgene product, whereas antibody against the C-terminal part of plakoglobin detects endogenous plakoglobin and transgene product, ⌬N122-PG. Panel E shows plakoglobin expression levels in skin samples from 3-month-old male wild-type and K5-PG mice (lines 1, 8, and 15) . Skin protein extracts from two wild-type and five K5-PG mice (one from line 15, two from lines 8 and 1) were analyzed with the anti-HA-tag antibody to detect transgene expression and with the antibody against the C-terminal part of plakoglobin recognizing both endogenous plakoglobin and transgene product (total plakoglobin). Note that total plakoglobin levels were not altered in the skin samples of transgenic mice. K5 served as a loading control. WT, wild type.
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Transgenic mice were generated by pronuclear injection of the purified K5-⌬N122-PG or K5-PG construct into fertilized oocytes from C57BL/6 mice. Animals were screened for transgene integration by PCR performed on genomic DNA isolated from tail snips. To determine the transgene copy number, the intensity of the radioactive signal for the transgenic probe was compared with genomic DNA from transgenic mice and the signals obtained with a graded copy number of the plasmid containing the transgenic constructs. Signals were quantified by using a Storm 860 PhosphorImager (Molecular Dynamics) and an ImageQuant program.
To generate mice with the K14 ϩ /Cre(neo)-␤cat lox/null-K5-⌬N122-PG genotype (referred to as K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG), K5-⌬N122-PG females (line 12) were mated with K14 ϩ /Cre(neo)-␤cat ϩ /null males, and the progeny was genotyped by PCR as previously described (23) . K14 ϩ /Cre(neo)-␤cat ϩ /null-K5-⌬N122-PG mice were mated with ␤-catenin lox/lox mice, and the resulting progeny was genotyped and analyzed.
Cultured keratinocytes and transfection. Pam212 keratinocytes were grown in Dulbecco's modified Eagle medium (Gibco BRL, Life Technologies S.A., Cergy Pontoise, France) supplemented with 10% fetal calf serum (Seromed, Biochrom KG, Berlin, Germany), 2 mM L-glutamine (Gibco BRL), and penicillin-streptomycin (Gibco BRL).
Transient transfection experiments were performed with the Geneporter reagent (Gene Therapy Systems Inc., San Diego, Calif.) according to the manufacturer's instructions. Cells were split into 24-well dishes at a density of 5 ϫ 10 After a 48-h incubation, cells were scraped into 100 l of passive lysis buffer (Promega) per well, and after two freeze-thaw cycles, lysates were cleared by centrifugation at 10,000 ϫ g and 4°C for 5 min. Luciferase activity in 20-l lysate aliquots was measured in a Lumat 9501 luminometer (Berthold, Pforzheim, Germany), by using firefly and Renilla substrates (Promega). The values obtained for firefly luciferase were corrected for transfection efficiency by using Renilla luciferase activity. At least three independent experiments were performed in triplicate in each case.
Whole-mount skin staining. Paw skin pieces from 6-month-old male wild-type and transgenic mice were spread on microscope slides and fixed overnight in Methacarn (60% methanol, 30% chloroform, 10% acetic acid), rehydrated, and stained with carmine alum for several days. Samples were dehydrated and cleared in xylene for observation.
BrdU incorporation assay, histology, and immunostaining. To assess cell proliferation, mice were injected intraperitoneally with 0.25 mg of 5-bromo-2Ј-deoxyuridine (BrdU)/g of body weight 2 h prior to sacrifice. Nuclear BrdU detection was performed on skin sections by using a cell proliferation kit (Amersham) according to the manufacturer's instructions.
Skin samples were fixed with 4% paraformaldehyde in phosphate-buffered saline or Methacarn and processed for embedding in paraffin. For histological analysis and immunohistochemistry, 7-m sections were cut. For immunohistochemistry, the sections were incubated in 1% H 2 O 2 to block endogenous peroxidase activity. To retrieve nuclear antigens on paraffin-embedded skin sections, slides were incubated for 10 min in 10 mM sodium citrate buffer, pH 6.0, at 90°C. Cryosections (7 m) were cut from skin pieces embedded in Tissue-Tek (Miles Diagnostic Division, Elkhart, Ind.) and frozen in isopentane cooled by liquid nitrogen. Before staining, cryosections were fixed in acetone for 10 min at Ϫ20°C.
Skin sections were incubated for 60 min in 5% fetal calf serum, then overnight with primary antibodies, and for 2 h at room temperature with appropriate secondary antibodies. Nuclei were stained with 1 g of DAPI (4Ј,6Ј-diamidino-2-phenylindole) (Sigma) per ml for immunofluorescence studies or counterstained with hematoxylin for immunohistochemistry.
Texas Red-, fluorescein isothiocyanate (1:100; Jackson Immunoresearch Laboratories)-or AlexaFluor (1:1,000; Molecular Probes)-conjugated secondary antibodies were used for immunofluorescence labeling, and the Envision ϩ System HRP kit (Dako) was used for immunohistochemistry.
Immunohistochemical detection of nuclear ␤-catenin, plakoglobin, HA-tag, c-Myc, and Engrailed-1 was performed with paraformaldehyde-fixed paraffinembedded tissue samples; detection of C/EBP␤, BrdU, and cyclin D1 was performed with Methacarn-fixed paraffin-embedded tissue and required antigen retrieval. All antikeratin antibodies were used on frozen or paraffin-embedded sections; anti-E-cadherin and antidesmoplakin were used on frozen sections.
RNA isolation, cDNA arrays, and real time reverse transcription (RT)-PCR. Total RNA was isolated from frozen shaved mouse back skin pieces with RNAPlus reagent (Bioprobe Systems, Montreuil-Sous-Bois, France). Five-microgram RNA samples were analyzed by cDNA array technology by using a signal transduction pathway finder gene array (SuperArray Inc., Bethesda, Md.) according to manufacturer's instructions. Quantitative analysis of the results was performed by using a PhosphorImager (Molecular Dynamics) and the ImageQuant program.
For real-time RT-PCR, the levels of c-Myc mRNA were normalized to the levels obtained for GAPDH (glyceraldehyde-3-phosphate dehydrogenase). The following primers were used: for mouse c-Myc, CAC CAG CAG CGA CTC TGA A and CCC GAC TCC GAC CTC TTG; for GAPDH, CCA ATG TGT CCG TCG TGG ATC and GTT GAA GTC GCA GGA GAC AAC.
Transmission electron microscopy. Skin samples were fixed in 2% glutaraldehyde in phosphate-buffered saline, followed by 2% glutaraldehyde in 0.1 M sodium cacodylate-HCl, pH 7.4, washed with 0.1 M sodium cacodylate-HCl, pH 7.4, postfixed with 1% OsO 4 in 0.15 M sodium cacodylate-HCl, pH 7.4, dehydrated in a graded series of ethanol and propylene oxide solutions, and embedded in Araldite resin. Ultrathin (60-to 80-nm) sections were prepared with an Ultracut apparatus (Reichert-Jung), contrast stained with uranyl acetate and lead citrate, and observed with a transmission electron microscope (LEO 912).
Protein analysis. For Western blotting, pieces of shaved dorsal skin (2 to 3 cm 2 ) from wild-type and transgenic mice were flash-frozen in liquid nitrogen, homogenized, and boiled in Laemmli's sample buffer. The supernatants were subjected to sodium dodecyl sulfide-polyacrylamide gel electrophoresis in 10% acrylamide gels. The separated proteins were electrophoretically transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore) which were probed with antibodies. Immunoblots were developed by using an ECL detection system (Amersham). To examine the subcellular distribution of E-cadherin and catenins, skin specimens from 2-month-old mice were homogenized and extracted with 1 ml of 50 mM Tris-HCl, pH 7.4, buffer containing 100 mM NaCl, 2 mM Ca2Cl, 1% NP-40, 1% Triton X-100, 2 mM phenylmethylsulfonyl fluoride, and 20 g of aprotinin per ml and centrifuged for 15 min at 15,000 ϫ g at 4°C. To extract the detergent-insoluble fraction, the pellet was boiled in 0.5 ml of Laemmli's sample buffer. Detergent-soluble protein fractions (0.1 mg) and equivalent amounts of the detergent-insoluble fractions were analyzed by Western blotting. For immunoprecipitation, 0.5 mg of the detergent-soluble fractions was used.
Antibodies. Rabbit anti-␤-catenin (Sigma-Aldrich); anti-C/EBP␤ (Santa Cruz Biotechnology); anti-Engrailed-1 (Abcam); anti-K1, -K5, -K6, and -K14 (all from Covance); anti c-Myc (N-262; Santa Cruz Biotechnology); rat anti-E-cadherin (Sigma); mouse anti-K10 (Dako); anti-desmoplakin IϩII (Boerhinger-Mannheim); anti-BrdU (Pharmingen); and anti-hair keratin AE13 (a gift from T. T. Sun) antibodies were used for immunohistochemistry. Rabbit anti-␣-catenin antibody (Sigma) was used for Western blotting; rabbit anti-HA-tag (Santa Cruz Biotechnology) and anti-cyclin D1 (Pharmingen) antibodies were used for immunohistochemistry and Western blotting; rat anti-E-cadherin (Zymed) and mouse anti-␤-catenin (Transduction Laboratories) antibodies were used for Western blotting and immunoprecipitation; rat anti-HA tag (Roche) and mouse anti-plakoglobin C terminus (Transduction Laboratories) antibodies were used for immunohistochemistry, Western blotting, and immunoprecipitation.
RESULTS
Generation of transgenic mice and transgene expression in the epidermis. We first estimated the transactivation capacities of plakoglobin and ⌬N122-PG by transiently cotransfecting cultured mouse keratinocytes (cell line Pam212) with the TOPFLASH luciferase reporter and plasmids encoding Nterminally truncated ␤-catenin (⌬N57-␤-catenin), plakoglobin, ⌬N122-PG, and Lef-1. In the absence of transfected Lef-1, ⌬N57-␤-catenin, plakoglobin, and ⌬N122-PG only weakly activated transcription from the TOPFLASH reporter, whereas the cotransfection of cells with Lef-1 and catenin constructs resulted in strong activation (Fig. 1B, left panel) . Plakoglobin and ⌬N122-PG enhanced transcription from the TOPFLASH reporter to similar extents, corresponding to about half of the activation achieved with ⌬N57-␤-catenin. The catenin constructs only weakly activated transcription from the control FOPFLASH reporter containing mutant Lef/Tcf binding sites. Similar results were obtained with the mouse keratinocyte cell line MCA3D (data not shown).
To investigate whether excess plakoglobin and ⌬N122-PG affected the ␤-catenin-induced activation of TOPFLASH, these two molecules were coexpressed in Pam212 cells, together with 1C) . Western blotting performed with anti-plakoglobin antibody recognizing the C terminus revealed endogenous plakoglobin and transgene product, ⌬N122-PG, in K5-⌬N122-PG mouse skin (Fig. 1D) . Comparison of the corresponding band intensities in Fig. 1D suggested that the transgene product levels in total skin extracts corresponded to approximately 20 to 25% of the endogenous plakoglobin amount. Surprisingly, we did not detect any significant change in the level of total plakoglobin (i.e., endogenous protein plus transgene product) in K5-PG transgenic lines (Fig. 1E) . ␤-Catenin levels were not visibly altered in K5-PG and K5-⌬N122-PG mouse skin extracts (Fig. 1C) . K5-PG mice appeared normal and presented no skin lesions on histological analysis within the 16-month observation period. In contrast, K5-⌬N122-PG mice (both females and males) had enlarged paws and irregularly thickened skin of the muzzle and the tail ( Fig. 2A) , a phenotype macroscopically similar to that of transgenic mice expressing N-terminally truncated ␤-catenin in basal keratinocytes (18, 28) . Histological analysis revealed that the back skin was also affected although to a lesser extent (data not shown). Manifestation of this phenotype depended on the transgene expression level. Macroscopically obvious skin lesions were only occasionally observed in 10-to 12-month-old animals expressing low levels of ⌬N122-PG, whereas in animals with medium (line 12) and high levels of transgene expression (lines 44 and 51), such lesions appeared at the ages of 5 to 6 and 2 to 3 months, respectively. These observations demonstrate that this phenotype results from transgene expression rather than the DNA integration site. The phenotype penetrance was 90% in the lines with high-level transgene expression and 70 to 80% in animals with medium-level expression.
In the most severely affected areas of the skin, all hair follicles were enlarged and abnormal in shape (Fig. 2B) . The histological abnormalities observed in K5-⌬N122-PG mice included thickened epidermis, hair and vibrissa follicle hyperplasia, and dermal cysts (Fig. 2C and D and data not shown) . Some of the hyperplastic hair follicles found in K5-⌬N122-PG mouse skin were reminiscent of human tumors known as trichofolliculomas ( Fig. 2C and D) .
In general, cell-cell contacts were not altered in the K5-⌬N122-PG epidermis, as estimated by transmission electron microscopy (Fig. 2E ). In animals with severe lesions only, cells in the epidermal basal and suprabasal layers were separated by wider intracellular spaces than those found in wild-type skin (Fig. 2E) . Such intercellular gaps have been observed in normal skin in healing wounds (19) .
Expression of ⌬N122-PG induces hyperplasia of the interfollicular epidermis. Expression of ⌬N122-PG driven by the K5 promoter resulted in a thickening of the epidermis, observed, in particular, on the tail, the muzzle, and the dorsal paw surface (Fig. 2 and 3) . In wild-type skin, K6 was detected only in hair follicles, whereas most of the basal cells in the epidermis of K5-⌬N122-PG mice stained positive for K6 (Fig. 3A) . Epidermal differentiation was not otherwise affected by the presence of the transgene product, as K10 was detected in the suprabasal layers (Fig. 3A) , and two other terminal differentiation markers-loricrin and fillagrin-were expressed in the upper layers of the epidermis (data not shown). Foci of BrdUincorporating cells were found in the interfollicular zones of the epidermal basal layer in K5-⌬N122-PG mice, indicating high rates of proliferation (Fig. 3B) . Large cell clusters with cyclin D1-positive nuclei were found in basal keratinocytes of the interfollicular zones of K5-⌬N122-PG epidermis. Far fewer cyclin D1-positive nuclei were detected in the wild-type skin (Fig. 3C) . Consistently, protein extracts from K5-⌬N122-PG mouse skin contained higher levels of cyclin D1 than those from wild-type animals (Fig. 3D) .
Expression of ⌬N122-PG induces hair follicle hyperplasia and dermal cysts. In K5-⌬N122-PG skin, novel hair follicle buds were formed from the outer root sheath of the preexisting hair follicles and from the epidermis (Fig. 2C and D and Fig.  4A and B) . The transgene product was detected with anti-HA-antibodies in the outermost cell layer of the aberrant hair follicles (Fig. 4A) . Hyperplastic hair follicles were surrounded by a continuous basement membrane, stained with anti-laminin antibodies (Fig. 4B) . The basement membrane surrounding abnormal hair follicles was often thickened and contained an unprocessed ␥2-laminin chain that was not deposited in the basement membrane in wild-type skin (data not shown). cDNA microarray analysis revealed that the levels of mRNA for En1, the mouse homolog of the Drosophila Engrailed transcription factor, were high in all K5-⌬N122-PG skin samples tested. In wild-type animals, En1 was present mostly in the lower, cycling part of hair follicles, with a particularly strong signal in precortex and matrix cells (Fig. 4C, frames a and b) . In K5-⌬N122-PG mice, the enlarged hair follicles and follicular cyst-like structures contained numerous En1-positive cells (Fig. 4C, frame c) . En1 expression in hyperplasia indicates its possible origin from the lower hair follicle part. Consistent with this view, little or no staining for En1 was detected in aberrant hair germs formed from the epidermis and in sebocyte-containing hyperplastic hair follicles (Fig. 4C,  frame c) .
Finally, many multilayered dermal cysts contributed to the increase in skin volume. Some of these cysts stained with the AE13 antibody that recognizes hair-specific cytokeratins (Fig.  4D) , whereas others expressed markers of epidermal differentiation (Fig. 4E) .
Localization of ⌬N122-PG in transgenic mouse skin. To evaluate the possible activation of ␤-catenin signaling by ⌬N122-PG expression, we analyzed the intracellular distribution of ⌬N122-PG and ␤-catenin in K5-⌬N122-PG mouse skin. In the epidermis, ⌬N122-PG was found at cell-cell boundaries, where its distribution correlated with that of desmoplakin (Fig. 5A) , suggesting that the transgene product was located in desmosomes. Only a few HA-tag-positive nuclei were detected in the basal cell layer of the epidermis in K5-⌬N122-PG mice (data not shown).
FIG. 4.
Hair follicle hyperplasia in K5-⌬N122-PG transgenic mouse skin. (A) Double immunofluorescence staining of a dorsal paw skin cryosection from a K5-⌬N122-PG 6-month-old male mouse (line 12) with anti-HA-tag revealing ⌬N122-PG and anti-E-cadherin antibodies. The transgene product is present in the outer cell layer of the aberrant hair follicles. Note dilated hair follicles, numerous aberrant hair germs, and hair follicles formed from the preexisting follicle. (B) Staining of the basement membrane surrounding the hyperplastic hair follicles found in K5-⌬N122-PG 6-month-old male mouse (line 12) dorsal paw skin with antilaminin antibody. (C) En1 expression in wild-type and K5-⌬N122-PG (line 51) skin. Immunohistochemistry performed on paraformaldehyde-fixed paraffin-embedded skin samples. Sections of back skin from a wild-type mouse showing hair follicles in anagen (a) and telogen (b). En1 was found only in the lower cycling part of hair follicles. In K5-⌬N122-PG mouse tail skin (c), numerous En1-positive cells were detected in aberrant hair follicles. Hair germs and tumors containing ectopic sebocytes showed no En1 staining. (D and E) Dermal cysts in K5-⌬N122-PG transgenic mouse skin (line 44). In a follicular cyst from the dorsal paw skin of a K5-⌬N122-PG mouse (D), numerous cells were stained with AE13 (green), an anti-hair follicle keratin antibody. K1 (red), an early epidermal keratinocyte terminal differentiation marker, was not detected. DAPI staining is shown in blue. In epidermoid cysts in K5-⌬N122-PG mouse muzzle skin, the cells of the outer wall layers expressed K5 (green), whereas K10 (red) was found in the innermost layers. c, cyst; dhf, dilated hair follicle; ec, epidermoid cyst; ep, epidermis; fc, follicular cyst; hhf, hyperplastic hair follicle; hg, hair follicle germ; m, matrix; pc, precortex; s, sebocyte. Bars ϭ 50 m (A, B, frames a and c of C, D, and E) and 25 m (C, frame b).
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In the hyperplastic hair follicles formed in K5-⌬N122-PG skin, HA-tag staining was observed at cell-cell boundaries and in the nuclei of the outer (basal) cell layer (Fig. 5B) . ␤-Catenin was also present in the nuclei of many basal cells (Fig. 5C) , indicating that the expression of ⌬N122-PG led to the stabilization and nuclear translocation of ␤-catenin.
In ␤-catenin-null epidermis, ⌬N122-PG does not induce the formation of new hair germs but restores the differentiation. The observed effects of ⌬N122-PG expression in the epidermis could be attributed either entirely to ␤-catenin, which was stabilized and accumulated in the nuclei due to the presence of the transgene product, or, at least in part, to the intrinsic ability of ⌬N122-PG to activate transcription via Lef/Tcf or other factors. To examine these possibilities, we introduced ⌬N122-PG into basal keratinocytes of ␤-catenin-null epidermis (mice referred to as K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG). The phenotypic characteristics of K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG mice are summarized in Table 1 . K5 promoter-driven expression of ⌬N122-PG in mice displaying conditional inactivation of the ␤-catenin gene increased survival rate, as in the 2-month observation period, 6 of 11 K14-␤cat Ϫ/Ϫ mice and only 1 of 8 K14-␤cat Histological analysis of skin samples from 2-and 6-monthold mice confirmed that the expression of ⌬N122-PG in ␤-catenin-null epidermis neither induced normal hair follicle cycling nor led to the formation of new hair germs or hair follicle tumors detected in the skin of K5-⌬N122-PG mice (Fig. 6A) . These results suggest that ␤-catenin-mediated events rather than intrinsic plakoglobin signaling activity induced the skin lesions in K5-⌬N122-PG mice.
In young animals, ␤-catenin-null epidermis was found to be abnormally thick and hyperproliferative (23) . In animals older than 4 to 5 months, this phenotype was less obvious. Since an earlier paper describing the phenotype of ␤-catenin-null skin focused on hair follicle defects, in this study, we examined interfollicular ␤-catenin-null epidermis in more detail. In ␤-catenin-null epidermis, proliferating cells were present in basal and suprabasal layers, whereas staining for basal cell K14 and for K6, a hyperproliferation marker, was observed in all cell layers (Fig. 6B ). In addition, many areas lacking K10, a marker of terminal keratinocyte differentiation, were found in the epidermis of K14-␤cat Ϫ/Ϫ mice (Fig. 6B) . As K10 expression is regulated by the transcription factor C/EBP␤ (29, 50), we compared the distribution of C/EBP␤ in mutant and wild-type epidermis. While in wild-type skin C/EBP␤ was concentrated in the nuclei of basal and some suprabasal keratinocytes, in ␤-catenin-null epidermis, the anti-C/EBP␤ antibody in addition stained the cytoplasm in all cell layers (Fig. 6B) . This abnormal intracellular localization suggests that activation of C/EBP␤ in ␤-catenin-null epidermis may be impaired.
In the K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG epidermis, BrdU-incorporating cells were found mostly in the basal layer. The expression of K6 and K5 or K14 was downregulated in the upper layers of the epidermis, whereas normal K10 expression was restored; and the intracellular distribution of C/EBP␤ was rather similar to that observed in wild-type skin, with C/EBP␤ found essentially in the nuclei of suprabasal cells (Fig. 6B) . Thus, the expression of ⌬N122-PG significantly restored the differentiation of ␤-catenin-null interfollicular epidermis.
Expression of ⌬N122-PG leads to c-Myc up-regulation in ␤-catenin-null epidermis. c-Myc, shown to be activated in some cells overexpressing plakoglobin (27) , is also an important regulator of epidermal keratinocyte differentiation (4, 16, 17, 48) . We therefore examined by real-time RT-PCR the effects of ⌬N122-PG on c-Myc expression in the epidermis. Expression of ⌬N122-PG in wild-type epidermis and inactivation of the ␤-catenin gene did not alter c-Myc mRNA levels. In contrast, in K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG epidermis, c-Myc levels were two times higher (Table 2 ). Immunofluorescence analysis of 1-to 2-month-old K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG mouse skin sections with anti-c-Myc antibodies detected nuclear c-Myc in many basal and suprabasal keratinocytes, while only weak diffuse staining and rare c-Myc-positive nuclei were observed in ␤-catenin-null epidermis (Fig. 6C) .
Subcellular distribution of catenins and E-cadherin in wildtype and mutant epidermis. Expression of ⌬N122-PG in the epidermis may induce changes in cell-cell adhesion. We therefore examined the effects of ⌬N122-PG on the composition of E-cadherin-catenin complexes and the distribution of E-cadherin and catenins in detergent-soluble and detergent-insoluble cellular fractions from wild-type and mutant epidermis from 2-month-old mice (Fig. 7A and B) .
Western blot analysis of these subcellular fractions showed no significant differences in the levels of E-cadherin and catenins in skin extracts from mutant and wild-type mice (Fig. 7A) . In all samples, E-cadherin and ␣-catenin were found essentially in the detergent-soluble fractions. A small amount of E-cadherin and ␣-catenin was also detected in the detergentinsoluble fractions, if the exposure time for the immunoblot development was increased (data not shown). ␤-Catenin was present in both the detergent-soluble and detergent-insoluble fractions of wild-type and K5-⌬N122-PG skin extracts. Although most of the plakoglobin was detergent-insoluble in all extracts, a slightly greater amount of detergent-soluble plakoglobin was detected in K5-⌬N122-PG, K14-␤cat Ϫ/Ϫ , and K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG skin. The amount of ⌬N122-PG in the detergent-soluble fractions was below detection levels.
The detergent-soluble fractions of skin extracts were used for immunoprecipitation assays (Fig. 7B) . In K5-⌬N122-PG skin, the amount of ␣-catenin coprecipitating with E-cadherin was similar to that in wild-type skin. Thus, the expression of ⌬N122-PG did not significantly prevent the binding of ␣-cate- nin to E-cadherin-containing complexes and the formation of adherens junctions. In contrast to what was observed for wildtype skin samples, endogenous plakoglobin and ⌬N122-PG were detected in E-cadherin immunoprecipitates from K5-⌬N122-PG extracts, suggesting that, to some extent, these molecules may replace ␤-catenin in E-cadherin-containing complexes. However, only very small amounts of E-cadherin and ␣-catenin were found in immunoprecipitates from K5-⌬N122-PG skin extracts obtained with anti-plakoglobin antibody. This indicates that only a small fraction of plakoglobin was associated with E-cadherin and ␣-catenin. Moreover, the anti-HA antibody did not precipitate detectable amounts of E-cadherin or ␣-catenin from K5-⌬N122-PG skin extracts. Thus, the expression of ⌬N122-PG did not interfere with the formation of adherens junctions in the epidermis. In ␤-catenin-null epidermis (K14-␤cat Ϫ/Ϫ and K14-␤cat Ϫ/Ϫ -K5-⌬N122-PG mice), the amount of ␣-catenin coprecipitating with E-cadherin was similar to that in wild-type extracts (Fig.  7B) . Consistent with the recent findings of Posthaus et al., plakoglobin coprecipitated with E-cadherin, whereas E-cadherin and ␣-catenin were found in immunoprecipitates obtained with anti-plakoglobin antibody (40) . This result suggests that, in ␤-catenin-null epidermis, plakoglobin replaced ␤-catenin in adherens junctions.
We investigated whether the recruitment of plakoglobin to adherens junctions affected desmosomes by analyzing the distribution of desmoplakin in ␤-catenin-null epidermis by confocal immunofluorescence microscopy. Weak irregular staining was observed in the basal and suprabasal layers of K14-␤cat Ϫ/Ϫ epidermis, whereas ⌬N122-PG expression resulted in stronger staining and a characteristically patchy distribution of desmoplakin at cell-cell boundaries (Fig. 5A and Fig. 7C ).
DISCUSSION
The expression of stabilized N-terminally truncated ␤-catenin under control of the K14 promoter has been shown to activate Tcf/␤-catenin signaling aberrantly in basal keratinocytes, inducing de novo hair follicle formation and tumors originating from the upper and lower hair follicles (18, 28) . We found that K5-⌬N122-PG mice presented a similar skin phenotype, with hair follicle hyperplasia displaying differentiation features characteristic of both the upper (i.e., hair keratinnegative, trichofolliculoma-like, and sebocyte-containing tumors) and lower (i.e., hair keratin-positive, expressing En1) hair follicles. These results suggest that ⌬N122-PG activates the Tcf/␤-catenin pathway or induces another signal that substitutes for that elicited by ␤-catenin. However, in ␤-cateninnull skin, ⌬N122-PG did not induce the formation of new hair germs and follicular tumors, suggesting that the abnormal hair follicles found in K5-⌬N122-PG mouse skin appear due to the aberrant activation of ␤-catenin signaling. Thus, even though in vitro, ⌬N122-PG activates transcription from Lef/Tcf target genes, it cannot substitute for ␤-catenin in its signaling functions in vivo. A recent study demonstrated that the interaction of plakoglobin with the adherens junction components E-cadherin and ␣-catenin could activate ␤-catenin signaling (33) . Consistent with this, immunoprecipitation assays showed that in K5-⌬N122-PG, but not in wild-type skin, a small amount of plakoglobin was present in E-cadherin-containing complexes. Part of the ␣-catenin-binding site (2) is deleted in ⌬N122-PG, and this molecule may therefore interfere with the recruitment of ␣-catenin to adherens junctions, thereby affecting cellcell adhesion in the epidermis. Several lines of evidence suggest that this is not the case. First, the amount of ␣-catenin coprecipitating with E-cadherin was not altered by transgene expression, implying that ⌬N122-PG did not prevent the binding of ␣-catenin to E-cadherin-containing complexes. Second, ⌬N122-PG was essentially restricted to the desmosomes, with only very small amounts found in complex with E-cadherin, as Ecadherin could not be immunoprecipitated with anti-HA antibody. This observation is consistent with the findings of Chitaev et al., who demonstrated that the affinity of plakoglobin for desmosomal cadherins is several times greater than that for E-cadherin (11) . Finally, ⌬N122-PG expression significantly improved the architecture and differentiation of ␤-catenin-null epidermis, suggesting that a dominant-negative effect of the transgene product on epidermal cell-cell adhesion is very unlikely.
In contrast to K5-⌬N122-PG mice, transgenic mice from the K5-PG lines did not display an abnormal skin phenotype. Although the levels of transgene product differed significantly in animals from different K5-PG lines, the total levels of plakoglobin (including the transgene product and endogenous plakoglobin) remained similar to those found in wild-type skin. These data are consistent with the observation that the expression of N-terminally truncated, rather than full-length, plakoglobin leads to the cytoplasmic accumulation of ectopic and endogenous plakoglobin in A431 squamous carcinoma cells (37) .
Charpentier et al. recently reported that moderate ectopic expression of N-terminally truncated or full-length-plakoglobin in basal keratinocytes under control of the K14 promoter (transgenic lines K14-PG and K14-⌬N80-PG) resulted in a mild phenotype different from that described here (9) . In these transgenic mice, during the two first growth cycles hair follicles prematurely (2 days earlier than wild-type littermates) terminated the growth phase, anagen, and entered into the regression phase, telogen (9) . The shortened hair follicle cycle resulted in somewhat shorter hairs. The phenotype became less obvious in the older mice, as noted by the authors, and all the data presented in the paper were obtained with mice younger than 45 days. In contrast, in K5-⌬N122-PG mice, macroscopically visible skin lesions appeared rather late, at the age of 2 to 3, 5 to 6, and 10 to 12 months in the animals with high, medium, and low transgene expression levels, respectively. The exact reasons for this difference in the phenotypes are not known. Although the K5 and K14 promoters have similar expression patterns and target transgenes to basal epithelia, the spatial and temporal regulation of the expression of the constructs used in the two studies might be slightly different. Further, the Swiss Webster genetic background may favor the subtle, early phenotype observed by Charpentier et al.
The notion that overexpression of plakoglobin can lead to the stimulation of ␤-catenin signaling in the mouse epidermis is in agreement with the results obtained earlier in Xenopus and in cultured cells of different origins (25, 26, 32, 45) . In addition, this study as well as the paper by Charpentier et al. (9) showed that plakoglobin and ⌬N-PG constructs activated TOPFLASH when transiently transfected into keratinocytes. Therefore, it can be suggested that relatively mild expression levels of the plakoglobin transgenes may inhibit hair follicle growth, whereas a more important increase of the total intracellular plakoglobin level achieved due to ⌬N-PG expression is required to stimulate ␤-catenin signaling. Thus, the data presented by Charpentier et al. and our findings may be considered complementary rather than contradictory.
A phenotype reminiscent of that described in this study was obtained by expression of N-and C-terminally truncated ␤-catenin in transgenic mouse epidermis (15) . On the one hand, ⌬N⌬C-␤-catenin expression may lead to the stabilization of endogenous ␤-catenin and aberrant activation of Tcf/␤-catenin signaling (52) . On the other hand, this molecule interferes with Tcf-mediated transactivation, acting as a dominant-negative inhibitor that lacks the transactivation domain. Consistently, in cultured keratinocytes ⌬N⌬C-␤-catenin inhibits activation of the TOPFLASH reporter (15) . In contrast, in our study ⌬N122-PG, when coexpressed with ␤-catenin, further augmented the activation of TOPFLASH, suggesting that different molecular mechanisms underlie the phenotypes resulting from expression of ⌬N122-PG and ⌬N⌬C-␤-catenin.
We found that ⌬N122-PG expression significantly improved the differentiation of interfollicular epidermis and increased the survival rate in mice with conditional inactivation of the ␤-catenin gene in the skin. Decreased survival of K14-␤cat Ϫ/Ϫ mice was also observed in the earlier study (23) . The death of pups occurred essentially at weeks 2 to 5 after birth and was found to be increased around weaning. This might be due to a defect in the esophagus of K14-␤cat Ϫ/Ϫ mice, since the K14 promoter is also active in this tissue. Mutant mice which survived this early crisis period were found to be viable and fertile (23) .
The alterations in cell growth and differentiation observed in ␤-catenin-null epidermis can be interpreted as hyperplasia of the basal layer or the uncontrolled proliferation of transient amplifying cells (23) . Interestingly, the depletion of ␤-catenin does not alter keratinocyte proliferation in culture (40) , suggesting that other factors characteristic of in vivo tissue organization, rather than the lack of ␤-catenin-signaling per se, are responsible for the phenotype of the ␤-catenin-null epidermis. Although plakoglobin was found to substitute for ␤-catenin in adherens junctions, no increase in the level of plakoglobin was detected in ␤-catenin-null skin. Thus, the recruitment of plakoglobin to adherens junctions may result in the depletion of VOL. 24, 2004 ROLE OF PLAKOGLOBIN IN THE EPIDERMIS 8659 this molecule from desmosomes, which may in turn lead to an increase in proliferation and changes in differentiation. The expression of ⌬N122-PG may restore the level of plakoglobin in the desmosomal compartment, thereby rescuing the differentiation of ␤-catenin-null keratinocytes. Consistently, the expression of ⌬N122-PG in ␤-catenin-null skin led to the restoration of a desmoplakin distribution pattern similar to that in wild-type skin. Several studies have suggested that desmosomal components are involved in the regulation of epidermal differentiation (3, 10, 31) , but their precise role in intracellular signaling events remains to be elucidated. Alternatively, or in addition, plakoglobin may be directly involved in the transcriptional regulation of genes not involved in hair follicle induction but essential for epidermal differentiation, such as c-Myc. The results of a recent study demonstrating that in ␤-catenin-null embryonic stem cells, plakoglobin can transactivate the promoters of Nr-CAM, cyclin D1, and Lef/Tcf reporter are in favor of such interpretation (12) . In either case, the capacity of ⌬N122-PG to rescue the differentiation of ␤-catenin-null epidermis strongly suggests that plakoglobin, either as an essential desmosomal constituent or as a signaling molecule regulating transcription, may influence epidermal differentiation.
